NOVO HOLDINGS A/S
Filing Date
Global Rank
#1,562
/ 8,607
▲ 14
· as of Mar 2026
Top Industry
Biotechnology
69.2%
3Y Alpha vs SPY
+14.0%
Period ended 3 months ago
Filed May 15, 2026 · 58d
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+141.5%
SPY
+75.2%
Annualised alpha
+13.6%
Max drawdown
−38.3%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
22 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
13.6%
+1.2 pts
Top 5
51.0%
+4.5 pts
Top 10
73.6%
+2.6 pts
HHI
729
Diversified+77
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 69.2% | $857,300,211 |
| Technology | 16.6% | $206,009,968 |
| Financial Services | 11.4% | $141,493,035 |
| Consumer Cyclical | 2.6% | $32,284,245 |
| Industrials | 0.2% | $2,531,949 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
3 positions
Trimmed
Positions the filer reduced
7 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| VALN | Valneva SE | −1,247,579 | 1,057,421 | $6,608,881 | |
| VRDN | Viridian Therapeutics, Inc.\DE | −380,000 | 2,000,000 | $39,120,000 | |
| ELVN | Enliven Therapeutics, Inc. | −200,000 | 1,280,000 | $50,176,000 | |
| APGE | Apogee Therapeutics, Inc. | −120,000 | 450,000 | $37,876,500 | |
| CRNX | Crinetics Pharmaceuticals, Inc. | −75,000 | 1,550,000 | $56,296,000 | |
| PCVX | Vaxcyte, Inc. | −56,160 | 860,000 | $49,974,600 | |
| ASML | Asml Holding NV | −19,000 | 94,946 | $125,407,525 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc. | 485,438 | $28,228,219 | |
| No positions match the current search. | ||||
22 positions ·
$1,239,619,408 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Held | 5,350,000 | $168,525,000 | 13.59% | |
| BN |
BROOKFIELD Corp /ON/
Financial Services
|
Held | 3,496,245 | $141,493,035 | 11.41% | |
| ASML |
Asml Holding NV
Technology
|
Reduced | 94,946 | $125,407,525 | 10.12% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Added | 1,325,000 | $122,403,500 | 9.87% | |
| MPLT |
MapLight Therapeutics, Inc.
Healthcare
|
Held | 3,686,622 | $74,949,025 | 6.05% | |
| CRM |
Salesforce, Inc.
Technology
|
Added | 393,187 | $73,396,217 | 5.92% | |
| CRNX |
Crinetics Pharmaceuticals, Inc.
Healthcare
|
Reduced | 1,550,000 | $56,296,000 | 4.54% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
Reduced | 1,280,000 | $50,176,000 | 4.05% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Reduced | 860,000 | $49,974,600 | 4.03% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Held | 1,750,000 | $49,437,500 | 3.99% | |
| AVBP |
ArriVent BioPharma, Inc.
Healthcare
|
Held | 1,942,142 | $44,805,215 | 3.61% | |
| VRDN |
Viridian Therapeutics, Inc.\DE
Healthcare
|
Reduced | 2,000,000 | $39,120,000 | 3.16% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Held | 1,200,000 | $38,064,000 | 3.07% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
Reduced | 450,000 | $37,876,500 | 3.06% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Held | 660,000 | $37,283,400 | 3.01% | |
| FDMT |
4D Molecular Therapeutics, Inc.
Healthcare
|
Held | 3,650,737 | $33,988,361 | 2.74% | |
| BABA |
Alibaba Group Holding Ltd
Consumer Cyclical
|
Held | 257,327 | $32,284,245 | 2.60% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
NEW | 485,438 | $28,228,219 | 2.28% | |
| BBOT |
BridgeBio Oncology Therapeutics, Inc.
Healthcare
|
Added | 2,185,923 | $19,564,010 | 1.58% | |
| MQ |
Marqeta, Inc.
Technology
|
Held | 441,558 | $7,206,226 | 0.58% | |
| VALN |
Valneva SE
Healthcare
|
Reduced | 1,057,421 | $6,608,881 | 0.53% | |
| LNZA |
LanzaTech Global, Inc.
Industrials
|
Held | 158,148 | $2,531,949 | 0.20% |